| 1 | Is chest imaging needed as part of pT1a renal cell carcinoma surveillance after surgical resection? (Charles D, Fitzgerald J, Landowski T, Cooper B, Yong R Jr, Everett R, See W, Jacobsohn K, Johnson S, Langenstroer P) Urol Oncol 2024 Jan;42(1):23.e1-23.e4 |
| 1 | Outcomes of Consolidative Nephrectomy following Primary Immunotherapy in Advanced Renal Cell Carcinoma: A Multicenter Analysis. (Hakimi K, Saidian A, Panian J, Barata P, Berg S, Chang SL, Saliby RM, Dzimitrowicz H, Emamekhoo H, Gross E, Kilari D, Lam E, Nguyen M, Meagher M, Wang L, Rauterkus GP, D'Andrea V, Yim K, Psutka S, Thapa B, Weise N, Zhang T, McKay RR, Derweesh IH) Clin Genitourin Cancer 2023 Dec;21(6):694-702 1 Citation |
| 1 | Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy. (Panian J, Saidian A, Hakimi K, Ajmera A, Anderson WJ, Barata P, Berg S, Signoretti S, Lee Chang S, D'Andrea V, George D, Dzimitrowicz H, El Zarif T, Emamekhoo H, Gross E, Kilari D, Lam E, Lashgari I, Psutka S, Rauterkus GP, Shabaik A, Thapa B, Wang L, Weise N, Yim K, Zhang T, Derweesh I, McKay RR) Oncologist 2024 Oct 03;29(10):870-877 3 Citations |
| 1 | Cystic MED15::TFE3 translocation renal cell carcinoma: histologic mimicker of multilocular cystic renal neoplasm of low malignant potential with review of the literature. (Doytcheva K, Gallan AJ, Wang P, Wanjari P, Segal J, Antic T) Hum Pathol 2023 Jun;136:25-33 8 Citations |
| 3 | Management of Acute Liver Dysfunction Due to Budd-Chiari Syndrome in the Setting of Tumor Thrombus and Advanced Renal Cell Carcinoma. (Stevens-Haas C, Maniar V, Dietrich P, Langenstroer P, Joyce L, White S, Kilari D, Hong J, Johnson S) Urology 2023 Mar;173:32-33 |
| 1 | Cabozantinib Safety With Different Anticoagulants in Patients With Renal Cell Carcinoma. (Shayeb AM, McManus HD, Urman D, Jani C, Zhang T, Dizman N, Meza L, Sivakumar A, Gan CL, Barata P, Bilen MA, Gao X, Heng D, Pal S, Narra R, Kilari D, Kaymakcalan MD, McGregor B, Choueiri TK, McKay RR) Clin Genitourin Cancer 2023 Feb;21(1):55-62 1 Citation |
| 1 | Real-world Practice Patterns and Safety of Concurrent Radiotherapy and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. (Loo Gan C, Huang J, Pan E, Xie W, Schmidt AL, Labaki C, Meza L, Bouchard G, Li H, Jackson-Spence F, Sánchez-Ruiz C, Powles T, Kumar SA, Weise N, Hall WA, Rose BS, Beuselinck B, Suarez C, Pal SK, Choueiri TK, Heng DYC, McKay RR) Eur Urol Oncol 2023 Apr;6(2):204-211 6 Citations |
| 2 | Bystander LECT2 amyloidosis in tumor nephrectomy. (Gallan AJ, Bhasin-Chhabra B, Kilari D, Johnson S, D'Souza A) CEN Case Rep 2023 Feb;12(1):104-109 1 Citation |
| 1 | VITREOUS SEEDING OF RENAL CELL CARCINOMA IN A PATIENT RECEIVING CHECKPOINT INHIBITORS. (Dajani O, Wong A, Coleman A, Shepherd EA, Wind KP, MacCumber MW) Retin Cases Brief Rep 2023 Nov 01;17(6):699-701 |
| 1 | The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma. (Ali M, Mooi J, Lawrentschuk N, McKay RR, Hannan R, Lo SS, Hall WA, Siva S) Eur Urol 2022 Dec;82(6):613-622 53 Citations |
| 1 | Clinicopathological Features and Surgical Outcomes of Small Bowel Metastasis from Renal Cell Carcinoma. (Kimura J, Okabayashi T, Sui K, Tabuchi M, Iwata J, Hata Y, Iiyama T, Ono N) Acta Med Okayama 2022 Apr;76(2):155-165 |
| 1 | NF2-mutated Renal Carcinomas Have Common Morphologic Features Which Overlap With Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma: A Comprehensive Study of 14 Cases. (Paintal A, Tjota MY, Wang P, Fitzpatrick C, Wanjari P, Stadler WM, Gallan AJ, Segal J, Antic T) Am J Surg Pathol 2022 May 01;46(5):617-627 18 Citations |
| 1 | Distal Tubular Hyperplasia: A Proposal for a Unique Form of Renal Tubular Proliferation Distinct From Papillary Adenoma. (Williamson SR, Al-Obaidy KI, Cheng L, Smith SC, Cox RM, McKenney JK, Gokden N, Phillips CL, Giannico GA, Gallan AJ, Przybycin CG, Grignon DJ) Am J Surg Pathol 2021 Apr 01;45(4):516-522 3 Citations |
| 1 | BAP1-Mutated Clear Cell Renal Cell Carcinoma. (Gallan AJ, Parilla M, Segal J, Ritterhouse L, Antic T) Am J Clin Pathol 2021 Apr 26;155(5):718-728 40 Citations |
| 1 | Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients. (Zhang T, Pabla S, Lenzo FL, Conroy JM, Nesline MK, Glenn ST, Papanicolau-Sengos A, Burgher B, Giamo V, Andreas J, Wang Y, Bshara W, Madden KG, Shirai K, Dragnev K, Tafe LJ, Gupta R, Zhu J, Labriola M, McCall S, George DJ, Ghatalia P, Dayyani F, Edwards R, Park MS, Singh R, Jacob R, George S, Xu B, Zibelman M, Kurzrock R, Morrison C) Oncoimmunology 2020 Jun 10;9(1):1773200 12 Citations |
| 1 | Upper gastrointestinal bleeding due to gastric metastasis of renal cell carcinoma. (Orosz E, Ali MA, Patel AV) Dig Liver Dis 2021 Oct;53(10):1354-1355 3 Citations |
| 1 | Salvage ipilimumab associated with a significant response in sarcomatoid renal cell carcinoma. (George G, Schmidt L, Tolat P, Riese M, Kilari D) J Immunother Cancer 2020 Feb;8(1) 4 Citations |
| 1 | Clinicopathologic Features of Small Renal Masses Associated With Distant Metastatic Disease. (Gallan AJ, Antic T) Am J Clin Pathol 2020 Apr 15;153(5):613-617 7 Citations |
| 1 | Occam's Razor or Hickam's Dictum: A Case of Myopathy Double Trouble. (Chen Z, Saini M, Jan K, Chai JY) Ann Acad Med Singap 2019 Aug;48(8):264-267 |
| 1 | A Multimodal and Pathological Analysis of a Renal Cell Carcinoma Metastasis to the Thyroid Gland 11 Years Post Nephrectomy. (Geisbush TR, Dymon Z, Gabriel MS, Yedavalli V) J Radiol Case Rep 2019 Apr;13(4):1-9 3 Citations |
| 2 | Evolving Trends for Selected Treatments of T1a Renal Cell Carcinoma. (Doolittle J, Piotrowski J, Zuk K, Jacobsohn K, Langenstroer P, See W, Johnson S) Urology 2019 Oct;132:136-142 27 Citations |
| 1 | Oncological outcomes and pathological characteristics of cT1 upstaging to pT3a renal cell carcinoma compared with de novo pT3a tumors. (Senguttuvan Karthikeyan V, Mallya A, Sivaraman A, Galiano M, Rozet F, Cathala N, Barret E, Mombet A, Prapotnich D, Sanchez-Salas R, Cathelineau X) Actas Urol Esp (Engl Ed) 2019 Jun;43(5):234-240 1 Citation |
| 1 | Percutaneous Cryoablation of Solitary, Sporadic Renal Cell Carcinoma: Outcome Analysis Based on Clear-Cell versus Papillary Subtypes. (Haddad MM, Schmit GD, Kurup AN, Schmitz JJ, Boorjian SA, Geske J, Thompson RH, Callstrom MR, Atwell TD) J Vasc Interv Radiol 2018 Aug;29(8):1122-1126 15 Citations |
| 1 | Variation in nuclear size and PD-L2 positivity correlate with aggressive chromophobe renal cell carcinoma. (Mostafa ME, Abdelkader A, Kuroda N, Pérez-Montiel D, Banerjee A, Hes O, Iczkowski KA) Ann Diagn Pathol 2018 Jun;34:31-35 1 Citation |
| 1 | Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature. (Haugh AM, Njauw CN, Bubley JA, Verzì AE, Zhang B, Kudalkar E, VandenBoom T, Walton K, Swick BL, Kumar R, Rana HQ, Cochrane S, McCormick SR, Shea CR, Tsao H, Gerami P) JAMA Dermatol 2017 Oct 01;153(10):999-1006 84 Citations |
| 3 | Immune Check Point Inhibition in Sarcomatoid Renal Cell Carcinoma: A New Treatment Paradigm. (Raychaudhuri R, Riese MJ, Bylow K, Burfeind J, Mackinnon AC, Tolat PP, Iczkowski KA, Kilari D) Clin Genitourin Cancer 2017 Oct;15(5):e897-e901 15 Citations |
| 1 | Renal mass biopsy and thermal ablation: should biopsy be performed before or during the ablation procedure? (Wells SA, Wong VK, Wittmann TA, Lubner MG, Best SL, Ziemlewicz TJ, Hinshaw JL, Lee FT Jr, Abel EJ) Abdom Radiol (NY) 2017 Jun;42(6):1773-1780 30 Citations |
| 1 | Percutaneous biopsy in large, locally advanced or metastatic renal tumors. (Wittmann TA, Abel EJ) Urol Oncol 2017 Mar;35(3):87-91 7 Citations |
| 2 | Synchronous Tumors: Adenocarcinoma of the Esophagus and Clear Cell Renal Carcinoma. (Narra RK, Alvarez Argote J, Mesologites T, Dasanu CA) Conn Med 2015 Aug;79(7):401-4 |
| 1 | Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: a phase I trial of bortezomib plus bevacizumab. (Falchook GS, Wheler JJ, Naing A, Jackson EF, Janku F, Hong D, Ng CS, Tannir NM, Lawhorn KN, Huang M, Angelo LS, Vishwamitra D, Hess K, Howard AN, Parkhurst KL, Amin HM, Kurzrock R) Oncotarget 2014 Nov 15;5(21):10280-92 53 Citations |
| 1 | Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art. (Randall JM, Millard F, Kurzrock R) Cancer Metastasis Rev 2014 Dec;33(4):1109-24 76 Citations |
| 1 | Use of multimodal imaging in the management of tumor embolism from the inferior vena cava through the right heart in a patient with renal cell carcinoma. (Colwell EM, Gandhi SD, Iqbal Z, Rashid ZA, Pagel PS) J Cardiothorac Vasc Anesth 2014 Oct;28(5):1421-4 3 Citations |
| 2 | Laparoscopic cryoablation for clinical stage T1 renal masses: long-term oncologic outcomes at the Medical College of Wisconsin. (Johnson S, Pham KN, See W, Begun FP, Langenstroer P) Urology 2014 Sep;84(3):613-8 35 Citations |
| 1 | Impact of warm versus cold ischemia on renal function following partial nephrectomy. (Eggener SE, Clark MA, Shikanov S, Smith B, Kaag M, Russo P, Wheat JC, Wolf JS Jr, Matin SF, Huang WC, Harel M, Cambio J, Shalhav AL, Raman JD) World J Urol 2015 Mar;33(3):351-7 13 Citations |
| 1 | Tumor enucleation vs sharp excision in minimally invasive partial nephrectomy: technical benefit without impact on functional or oncologic outcomes. (Mukkamala A, Allam CL, Ellison JS, Hafez KS, Miller DC, Montgomery JS, Weizer AZ, Wolf JS Jr) Urology 2014 Jun;83(6):1294-9 47 Citations |
| 1 | Regulation of ferroptotic cancer cell death by GPX4. (Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB, Brown LM, Girotti AW, Cornish VW, Schreiber SL, Stockwell BR) Cell 2014 Jan 16;156(1-2):317-331 5168 Citations |
| 1 | A phase I, open-label study of trebananib combined with sorafenib or sunitinib in patients with advanced renal cell carcinoma. (Hong DS, Gordon MS, Samlowski WE, Kurzrock R, Tannir N, Friedland D, Mendelson DS, Vogelzang NJ, Rasmussen E, Wu BM, Bass MB, Zhong ZD, Friberg G, Appleman LJ) Clin Genitourin Cancer 2014 Jun;12(3):167-177.e2 23 Citations |
| 1 | Association of RENAL nephrometry score with outcomes of minimally invasive partial nephrectomy. (Ellison JS, Montgomery JS, Hafez KS, Miller DC, He C, Wolf JS Jr, Weizer AZ) Int J Urol 2013 Jun;20(6):564-70 48 Citations |
| 1 | A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas. (Hong DS, Kurzrock R, Supko JG, He X, Naing A, Wheler J, Lawrence D, Eder JP, Meyer CJ, Ferguson DA, Mier J, Konopleva M, Konoplev S, Andreeff M, Kufe D, Lazarus H, Shapiro GI, Dezube BJ) Clin Cancer Res 2012 Jun 15;18(12):3396-406 206 Citations |
| 1 | RETRACTED: Differential effects of VEGFR-1 and VEGFR-2 inhibition on tumor metastases based on host organ environment. (Lee YJ, Karl DL, Maduekwe UN, Rothrock C, Ryeom S, D'Amore PA, Yoon SS) Cancer Res 2010 Nov 01;70(21):8357-67 54 Citations |
| 1 | Tissue microarrays: one size does not fit all. (Eckel-Passow JE, Lohse CM, Sheinin Y, Crispen PL, Krco CJ, Kwon ED) Diagn Pathol 2010 Jul 07;5:48 40 Citations |
| 1 | Epidermal growth factor receptor mutation and diverse tumors: case report and concise literature review. (Chintala L, Kurzrock R) Mol Oncol 2010 Aug;4(4):306-8 17 Citations |
| 1 | Down-regulation of 20-HETE synthesis and signaling inhibits renal adenocarcinoma cell proliferation and tumor growth. (Alexanian A, Rufanova VA, Miller B, Flasch A, Roman RJ, Sorokin A) Anticancer Res 2009 Oct;29(10):3819-24 48 Citations |
| 2 | Deep hypothermic circulatory arrest for a patient with known cold agglutinins. (Pecsi SA, Almassi GH, Langenstroer P) Ann Thorac Surg 2009 Oct;88(4):1326-7 14 Citations |
| 1 | Multifocality incidence and accompanying clinicopathological factors in renal cell carcinoma. (Sargin SY, Ekmekcioglu O, Arpali E, Altinel M, Voyvoda B) Urol Int 2009;82(3):324-9 9 Citations |
| 1 | Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma. (Parker AS, Leibovich BC, Lohse CM, Sheinin Y, Kuntz SM, Eckel-Passow JE, Blute ML, Kwon ED) Cancer 2009 May 15;115(10):2092-103 100 Citations |
| 1 | Phase II trial of carboplatin and paclitaxel in papillary renal cell carcinoma. (Bylow KA, Atkins MB, Posadas EM, Stadler WM, McDermott DF) Clin Genitourin Cancer 2009 Jan;7(1):39-42 16 Citations |
| 1 | Increased expression of CD44s in conventional renal cell carcinomas with renal vein or vena cava thrombosis. a retrospective evaluation of the expression of CD44s by immunohistochemical analysis in conventional RCC patients and in conventional RCC patients with renal vein or vena cava thrombosis. (Altinel M, Arpali E, Turhan N, Gonenc F, Yazicioglu A) Urol Int 2008;81(4):452-5 6 Citations |
| 1 | Renal cell carcinoma in two patients with crossed fused ectopic kidneys. (Davis CM, Rao MV, Flanigan RC, Quek ML) Urol Int 2008;81(3):370-2 9 Citations |
| 1 | Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma. (Crispen PL, Sheinin Y, Roth TJ, Lohse CM, Kuntz SM, Frigola X, Thompson RH, Boorjian SA, Dong H, Leibovich BC, Blute ML, Kwon ED) Clin Cancer Res 2008 Aug 15;14(16):5150-7 236 Citations |
| 1 | Multiple squamous cell carcinomas of the skin after therapy with sorafenib combined with tipifarnib. (Hong DS, Reddy SB, Prieto VG, Wright JJ, Tannir NM, Cohen PR, Diwan AH, Evans HL, Kurzrock R) Arch Dermatol 2008 Jun;144(6):779-82 45 Citations |
| 1 | Comparison of digital image analysis versus visual assessment to assess survivin expression as an independent predictor of survival for patients with clear cell renal cell carcinoma. (Parker AS, Lohse CM, Leibovich BC, Cheville JC, Sheinin YM, Kwon ED) Hum Pathol 2008 Aug;39(8):1176-84 14 Citations |
| 1 | External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma. (Hoffmann NE, Sheinin Y, Lohse CM, Parker AS, Leibovich BC, Jiang Z, Kwon ED) Cancer 2008 Apr 01;112(7):1471-9 119 Citations |
| 1 | Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma. (Margulis V, Tamboli P, Jacobsohn KM, Swanson DA, Wood CG) BJU Int 2007 Dec;100(6):1235-9 56 Citations |
| 1 | Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib. (Tamaskar I, Bukowski R, Elson P, Ioachimescu AG, Wood L, Dreicer R, Mekhail T, Garcia J, Rini BI) Ann Oncol 2008 Feb;19(2):265-8 128 Citations |
| 1 | Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma. (Leibovich BC, Sheinin Y, Lohse CM, Thompson RH, Cheville JC, Zavada J, Kwon ED) J Clin Oncol 2007 Oct 20;25(30):4757-64 164 Citations |
| 1 | Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other. (Tollefson MK, Thompson RH, Sheinin Y, Lohse CM, Cheville JC, Leibovich BC, Kwon ED) Cancer 2007 Aug 15;110(4):783-90 63 Citations |
| 1 | Adjuvant therapy for renal cell carcinoma. (Jacobsohn KM, Wood CG) Semin Oncol 2006 Oct;33(5):576-82 38 Citations |
| 1 | Intermediate results of laparoscopic cryoablation in 59 patients at the Medical College of Wisconsin. (Lawatsch EJ, Langenstroer P, Byrd GF, See WA, Quiroz FA, Begun FP) J Urol 2006 Apr;175(4):1225-9; discussion 1229 54 Citations |
| 1 | Phase I trial of a monoclonal antibody specific for alphavbeta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion. (McNeel DG, Eickhoff J, Lee FT, King DM, Alberti D, Thomas JP, Friedl A, Kolesar J, Marnocha R, Volkman J, Zhang J, Hammershaimb L, Zwiebel JA, Wilding G) Clin Cancer Res 2005 Nov 01;11(21):7851-60 141 Citations |
| 1 | Chromophobe renal cell carcinoma in a pediatric living-related kidney transplant recipient. (Greco AJ, Baluarte JH, Meyers KE, Sellers MT, Suchi M, Biegel JA, Kaplan BS) Am J Kidney Dis 2005 Jun;45(6):e105-8 22 Citations |
| 1 | GLUT1 immunoreaction patterns reliably distinguish hemangioblastoma from metastatic renal cell carcinoma. (North PE, Mizeracki A, Mihm MC Jr, Mrak RE) Clin Neuropathol 2000;19(3):131-7 27 Citations |
| 1 | Renal-ovarian axis: a case report and review. (Gavallos G, Tawfik O, Herrell D, Langenstroer P) Urology 2003 Oct;62(4):749 15 Citations |
| 1 | Giant renal cell carcinoma directly invading the heart. (Schena S, Gilleran J, Chernoff A, Massad MG) Eur J Cardiothorac Surg 2003 Jun;23(6):1054-5 |
| 1 | Pancreatic leak after left pancreatectomy is reduced following main pancreatic duct ligation. (Bilimoria MM, Cormier JN, Mun Y, Lee JE, Evans DB, Pisters PW) Br J Surg 2003 Feb;90(2):190-6 216 Citations |
| 1 | Novel modification of partial nephrectomy technique using porcine small intestine submucosa. (O'connor RC, Harding JN 3rd, Steinberg GD) Urology 2002 Nov;60(5):906-9 21 Citations |
| 1 | Autocrine interleukin-6 production in renal cell carcinoma: evidence for the involvement of p53. (Angelo LS, Talpaz M, Kurzrock R) Cancer Res 2002 Feb 01;62(3):932-40 87 Citations |
| 1 | Ballistic-choreic movements as the presenting feature of renal cancer. (Kujawa KA, Niemi VR, Tomasi MA, Mayer NW, Cochran E, Goetz CG) Arch Neurol 2001 Jul;58(7):1133-5 40 Citations |
| 1 | Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma. (Dhanabal M, Ramchandran R, Volk R, Stillman IE, Lombardo M, Iruela-Arispe ML, Simons M, Sukhatme VP) Cancer Res 1999 Jan 01;59(1):189-97 260 Citations |
| 1 | Interleukin-1 increases expression of the LYT-10 (NFkappaB2) proto-oncogene/transcription factor in renal cell carcinoma lines. (Kurzrock R, Estrov Z, Ku S, Leonard M, Talpaz M) J Lab Clin Med 1998 Mar;131(3):261-8 5 Citations |
| 1 | Phase II studies of recombinant human interferon gamma in metastatic renal cell carcinoma. (Quesada JR, Kurzrock R, Sherwin SA, Gutterman JU) J Biol Response Mod 1987 Feb;6(1):20-7 78 Citations |
